In the context of the tumor microenvironment, SDC2 has been shown to be expressed on stromal cells within breast cancer tissue and positively modulates the transforming growth factor-β (TGF-β) signaling mainly through SMAD7, PAI-1, and CXCR4 [58]. The gene discussed is SDC2; the disease is neoplasm.